Arterial cardiovascular events are the leading cause of death in patients with JAK2V617F myeloproliferative neoplasms (MPNs). However, their mechanisms are poorly understood. The high prevalence of myocardial infarction without significant coronary stenosis or atherosclerosis in patients with MPNs suggests that vascular function is altered. The consequences of JAK2V617F mutation on vascular reactivity are unknown. We observe here increased responses to vasoconstrictors in arteries from Jak2V617F mice resulting from a disturbed endothelial NO pathway and increased endothelial oxidative stress. This response was reproduced in WT mice by circulating microvesicles isolated from patients carrying JAK2V617F and by erythrocyte-derived microvesicles from transgenic mice. Microvesicles of other cellular origins had no effect. This effect was observed ex vivo on isolated aortas, but also in vivo on femoral arteries. Proteomic analysis of microvesicles derived from JAK2V617F erythrocytes identified increased expression of myeloperoxidase as the likely mechanism accounting for their effect. Myeloperoxidase inhibition in microvesicles derived from JAK2V617F erythrocytes suppressed their effect on oxidative stress. Antioxidants such as simvastatin and N-acetyl cysteine improved arterial dysfunction in Jak2V617F mice. In conclusion, JAK2V617F MPNs are characterized by exacerbated vasoconstrictor responses resulting from increased endothelial oxidative stress caused by circulating erythrocyte-derived microvesicles. Simvastatin appears to be a promising therapeutic strategy in this setting.
Johanne Poisson, Marion Tanguy, Hortense Davy, Fatoumata Camara, Marie-Belle El Mdawar, Marouane Kheloufi, Tracy Dagher, Cécile Devue, Juliette Lasselin, Aurélie Plessier, Salma Merchant, Olivier Blanc-Brude, Michèle Souyri, Nathalie Mougenot, Florent Dingli, Damarys Loew, Stephane N. Hatem, Chloé James, Jean-Luc Villeval, Chantal M. Boulanger, Pierre-Emmanuel Rautou
Title and authors | Publication | Year |
---|---|---|
Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
Grenier JM, El Nemer W, De Grandis M |
International journal of molecular sciences | 2024 |
Inflammation as a cause of acute myocardial infarction in patients with myeloproliferative neoplasm
Tirandi A, Schiavetta E, Maioli E, Montecucco F, Liberale L |
World journal of cardiology | 2024 |
Metabolite and protein shifts in mature erythrocyte under hypoxia.
Jin X, Zhang Y, Wang D, Zhang X, Li Y, Wang D, Liang Y, Wang J, Zheng L, Song H, Zhu X, Liang J, Ma J, Gao J, Tong J, Shi L |
iScience | 2024 |
Extracellular vesicles and their effect on vascular haemodynamics: a systematic review.
Cheung SWY, Chamley LW, Barrett CJ, Lau SYS |
Hypertension research : official journal of the Japanese Society of Hypertension | 2024 |
Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms
Găman MA, Srichawla BS, Chen YF, Roy P, Dhali A, Nahian A, Manan MR, Kipkorir V, Suteja RC, Simhachalam Kutikuppala LV, Găman AM, Diaconu CC |
World journal of clinical oncology | 2024 |
Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis
Bourrienne MC, Le Cam Duchez V, Faille D, Farkh C, Solo Nomenjanahary M, Gay J, Loyau S, Journé C, Dupont S, Ollivier V, Villeval JL, Plo I, Edmond V, Jandrot-Perrus M, Labrouche-Colomer S, Cassinat B, Verger E, Desilles JP, Ho-Tin-Noé B, Triquenot Bagan A, Mazighi M, Ajzenberg N |
Blood Advances | 2024 |
Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms
Zhang H, Kafeiti N, Masarik K, Lee S, Yang X, Zheng H, Zhan H |
Arteriosclerosis, Thrombosis, and Vascular Biology | 2024 |
Unlocking the Role of Endothelial MPL Receptor and JAK2V617F Mutation: Insights into Cardiovascular Dysfunction in MPNs and CHIP
Zhang H, Kafeiti N, Lee S, Masarik K, Zheng H, Zhan H |
2023 | |
Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis
Wenli Liu, Nataliya K. Östberg, Mustafa Yalcinkaya, Huijuan Dou, Kaori Endo-Umeda, Yang Tang, Xintong Hou, Tong Xiao, Trevor Filder, Sandra Abramowicz, Yong-Guang Yang, Oliver Soehnlein, Alan Tall, Nan Wang. |
Journal of Clinical Investigation | 2022 |
JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms
D Torres, J Paes, A da Costa, A Malheiro, G Silva, L de Souza Mourão, A Tarragô |
Biomolecules | 2022 |
JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
H Hekimoğlu, S Toprak, S Sözer |
Turkish Journal of Hematology | 2022 |
Red Blood Cell Morphodynamics in Patients with Polycythemia Vera and Stroke
P Kuznetsova, A Raskurazhev, A Shabalina, A Melikhyan, I Subortseva, M Tanashyan |
International journal of molecular sciences | 2022 |
Roles and Applications of Red Blood Cell-Derived Extracellular Vesicles in Health and Diseases
Yang L, Huang S, Zhang Z, Liu Z, Zhang L |
International journal of molecular sciences | 2022 |
Brain-Derived Extracellular Vesicles Induce Vasoconstriction and Reduce Cerebral Blood Flow in Mice
Wang J, Xie X, Wu Y, Zhou Y, Li Q, Li Y, Xu X, Wang M, Murdiyarso L, Houck K, Hilton T, Chung D, Dong JF, Li M, Zhang J |
Journal of Neurotrauma | 2022 |
Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
Leiva O, Hobbs G, Ravid K, Libby P |
2022 | |
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
Nowakowska MK, Kim T, Thompson MT, Bolton KL, Deswal A, Lin SH, Scheet P, Wehner MR, Nead KT |
American Journal of Hematology | 2022 |
Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?
Lazana I |
International journal of molecular sciences | 2022 |
JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.
Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H |
Nature Communications | 2022 |
Exploration of cerebral vasospasm from the perspective of microparticles
Gao Y, Li K, Li X, Li Q, Wang J, Zhang S, Zhang J |
Frontiers in neuroscience | 2022 |
Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
BN Reeves, JD Beckman |
Current Hematologic Malignancy Reports | 2021 |
Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow
RJ Asaro, P Cabrales |
Diagnostics | 2021 |
Role of extracellular vesicles in liver diseases and their therapeutic potential
E Kostallari, S Valainathan, L Biquard, VH Shah, PE Rautou |
Advanced Drug Delivery Reviews | 2021 |
Germline risk of clonal haematopoiesis
AJ Silver, AG Bick, MR Savona |
Nature Reviews Genetics | 2021 |
Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
MA Găman, MA Cozma, EC Dobrică, SM Crețoiu, AM Găman, CC Diaconu |
Life Sciences | 2021 |
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters
L Catani, M Cavo, F Palandri |
Cells | 2021 |
Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
M Castiglione, YP Jiang, C Mazzeo, S Lee, JS Chen, K Kaushansky, W Yin, RZ Lin, H Zheng, H Zhan |
Journal of Thrombosis and Haemostasis | 2020 |
System-wide molecular dynamics of endothelial dysfunction in Gram-negative sepsis
X Gallart-Palau, A Serra, SK Sze |
BMC Biology | 2020 |
Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy
K Thangaraju, SN Neerukonda, U Katneni, PW Buehler |
International journal of molecular sciences | 2020 |
The possible role of mutated endothelial cells in myeloproliferative neoplasms
M Farina, D Russo, R Hoffman |
Haematologica | 2020 |